K.B. Bourloud

Type de document

Articles (5)

Co-auteur

Date

Source

Mot-clé

Tumors (5) Neuroblastoma (5) Cells (5) tumeur (3) Treatment (3) Apoptosis (3) Mice (3) Human beings (3) Expression (3) Children (3) toxicité (2) spectacle (2) modèle (2) gène (2) maladie (2) ligne (2) survie (2) Inhibitors (2) Hydroxamic acids (2) Tissues (2) Survival (2) Proteins (2) Nudity (2) Growth (2) Example (2) Enzyme inhibitors (2) Cell proliferation (2) Cell lines (2) Cell cycle (2) Arrest (2)

Documents écrit par K.B. Bourloud (5) | parle de K.B. Bourloud (0)

The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation.
K. Abid et al. (5 janv. 2021)
Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
G. Montavon et al. (2014)
Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
A. Mühlethaler-Mottet et al. (2008)
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
R. Meier et al. (2007)
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
A. Mühlethaler-Mottet et al. (2006)